{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "mGluR1 antagonists as therapeutic agents", "item": "https://www.patentleaderboard.com/patent/7485648"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › mGluR1 antagonists as therapeutic agents

mGluR1 antagonists as therapeutic agents

US Patent 7485648 · Granted Feb 3, 2009

Estimated economic value: $93,211,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Locally-induced adipose tissue browning by microneedle patch for obesity treatme2023
Cyclic di-nucleotide compounds as sting agonists2023
Compounds, compositions and methods of use2023
Cyclic di-nucleotide compounds as sting agonists2022
Carbamate and urea compounds as multikinase inhibitors2022
Cyclic compounds as immunomodulating agents2021
Macrocyclic compounds as TRK kinase inhibitors and uses thereof2021
C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as2021
C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as2020
Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic ace2019
Compound useful for altering the levels of bile acids for the treatment of diabe2019
Compounds useful for altering the levels of bile acids for the treatment of diab2019